Anthony Tang, ACC 2021: Findings from the RAFT-AF Trial

It was a great pleasure to meet with Anthony Tang to discuss the RAFT-AF trial results investigating the safety and efficacy of catheter ablation-based rhythm control compared with rate control for the treatment of patients with atrial fibrillation and heart failure, presented at ACC 2021. Abstract Title: A Randomized Ablation-based atrial Fibrillation rhythm control versus […]

Sanjiv Narayan, EHRA 2021 – AI and ML Models in Arrhythmias and Cardiac Electrophysiology

It was a pleasure to talk to Dr Sanjiv Narayan (Stanford University, Stanford, CA, USA) around the implementation of artificial intelligence and machine learning models in the field of arrhythmias and cardiac electrophysiology. Questions What are the major challenges in implementing artificial intelligence (AI) and machine learning (ML) models in the field of arrhythmias and […]

Federico Asch, ACC 2021 – Findings from the WASE COVID study

Federico Asch (MedStar Health Research Institute, Columbia, MD, USA) discusses the findings of the WASE COVID study, presented at ACC 2021. The study compared AI software-based echocardiography analysis with manual expert analysis to predict mortality based on longitudinal strain and LVEF. Abstract title: Human vs Machine Learning-based Echocardiography Analysis as Predictor of Outcomes in Acute […]

William Schulyer-Jones, ACC 2021 – Findings from the ADAPTIVE study

We were delighted to speak with Dr William Schulyer-Jones (Associate Professor of Medicine, Duke University School of Medicine, Durham, NC, USA) about the findings of the ADAPTABLE STUDY, a large randomized study assessing the benefits and long-term effectiveness of aspirin dosage (81 mg vs. 325mg) for patients with cardiovascular disease. Abstract title: Aspirin Dosing: A […]

COVID-19 and Cardiac Arrhythmias

European Journal of Arrhythmia & Electrophysiology. 2021;7(1):Online ahead of journal publication

The current outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has developed into a worldwide pandemic affecting millions of lives in one way or another.1 Over the period of 1 year since the disease was first reported from Wuhan, China,2 COVID-19 has infected over 50 million patients and resulted […]

Medical Therapy for Secondary Prevention of Atherothrombotic Events in Peripheral Artery Disease

Heart International. 2021;15(1):Online ahead of journal publication

Peripheral artery disease (PAD) is a severe manifestation of systemic atherosclerotic disease that commonly refers to lower-extremity arterial involvement. The global burden of PAD is estimated to involve over 200 million patients, with prevalence increasing by 24% over the past decade.1 In contrast to myocardial infarction and stroke, which are declining in the USA, the […]

Dual Antiplatelet Therapy in Patients with High Cardiovascular Risk

Heart International. 2021;15(1):Online ahead of journal publication

Coronary artery disease (CAD) is encountered on a daily basis in the field of medicine. Between 2009 and 2012, the global prevalence of CAD was 154 million, based on data from the Global Burden of Disease study; for the same period in the USA, it was approximately 15.5 million, based on data collected by the […]

The Role of Rilonacept in Recurrent Pericarditis

Heart International. 2021;15(1):Online ahead of journal publication

Pericarditis is the most common form of pericardial disease, with an incidence of 27.7 cases per 100,000 population per year.1 Approximately 15–30% of patients with acute pericarditis will have a first recurrence within 18 months despite optimal medical therapy. Half of these patients will fail to achieve complete remission and will continue to have recurrent […]